2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine

C170H156N16O4 — CID 158552690

About 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine

2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine (PubChem CID 158552690) has the molecular formula C170H156N16O4 and a molecular weight of 2487.23 g/mol. Its IUPAC name is 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine.

Molecular Properties

• Compound Name: 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine
• PubChem CID: 158552690
• Molecular Formula: C170H156N16O4
• Molecular Weight: 2487.23 g/mol
• Exact Mass: 2485.25
• IUPAC Name: 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine
• SMILES: CC1(C)COC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)CO5)cc4)c4ccccc34)cc2)=N1.CC1(C)N=C(c2ccccc2)N(c2cccc(-c3c4ccccc4c(-c4cccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)n4)c4cc(-c5ccccc5)ccc34)n2)C1(C)C.CC1=NC(C)(C)C(C)(C)N1c1cccc(-c2c3ccccc3c(-c3cccc(N4C(C)=NC(C)(C)C4(C)C)n3)c3cc(-c4ccccc4)ccc23)n1.c1ccc2c(-c3ccc(C4=NCCO4)cc3)c3ccccc3c(-c3ccc(C4=NCCO4)cc3)c2c1
• InChI: InChI=1S/C56H52N6.C46H48N6.C36H32N2O2.C32H24N2O2/c1-53(2)55(5,6)61(51(59-53)38-24-14-10-15-25-38)47-32-20-30-45(57-47)49-41-28-18-19-29-42(41)50(44-36-40(34-35-43(44)49)37-22-12-9-13-23-37)46-31-21-33-48(58-46)62-52(39-26-16-11-17-27-39)60-54(3,4)56(62,7)8;1-29-49-43(3,4)45(7,8)51(29)39-24-16-22-37(47-39)41-33-20-14-15-21-34(33)42(36-28-32(26-27-35(36)41)31-18-12-11-13-19-31)38-23-17-25-40(48-38)52-30(2)50-44(5,6)46(52,9)10;1-35(2)21-39-33(37-35)25-17-13-23(14-18-25)31-27-9-5-7-11-29(27)32(30-12-8-6-10-28(30)31)24-15-19-26(20-16-24)34-38-36(3,4)22-40-34;1-2-6-26-25(5-1)29(21-9-13-23(14-10-21)31-33-17-19-35-31)27-7-3-4-8-28(27)30(26)22-11-15-24(16-12-22)32-34-18-20-36-32/h9-36H,1-8H3;11-28H,1-10H3;5-20H,21-22H2,1-4H3;1-16H,17-20H2
• InChIKey: HPXMDWZFAUCBHX-UHFFFAOYSA-N
• XLogP: 40.13
• TPSA: 200.32 Ų
• H-Bond Acceptors: 20
• Rotatable Bonds: 20
• Heavy Atoms: 190
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2487.23
LogP ≤ 5	40.13
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	20

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine?

The IUPAC name of 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine (CID 158552690) is 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine.

What is the SMILES notation for 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine?

The canonical SMILES for 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine is CC1(C)COC(c2ccc(-c3c4ccccc4c(-c4ccc(C5=NC(C)(C)CO5)cc4)c4ccccc34)cc2)=N1.CC1(C)N=C(c2ccccc2)N(c2cccc(-c3c4ccccc4c(-c4cccc(N5C(c6ccccc6)=NC(C)(C)C5(C)C)n4)c4cc(-c5ccccc5)ccc34)n2)C1(C)C.CC1=NC(C)(C)C(C)(C)N1c1cccc(-c2c3ccccc3c(-c3cccc(N4C(C)=NC(C)(C)C4(C)C)n3)c3cc(-c4ccccc4)ccc23)n1.c1ccc2c(-c3ccc(C4=NCCO4)cc3)c3ccccc3c(-c3ccc(C4=NCCO4)cc3)c2c1.

What is the InChIKey of 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine?

The InChIKey is HPXMDWZFAUCBHX-UHFFFAOYSA-N. The full InChI is InChI=1S/C56H52N6.C46H48N6.C36H32N2O2.C32H24N2O2/c1-53(2)55(5,6)61(51(59-53)38-24-14-10-15-25-38)47-32-20-30-45(57-47)49-41-28-18-19-29-42(41)50(44-36-40(34-35-43(44)49)37-22-12-9-13-23-37)46-31-21-33-48(58-46)62-52(39-26-16-11-17-27-39)60-54(3,4)56(62,7)8;1-29-49-43(3,4)45(7,8)51(29)39-24-16-22-37(47-39)41-33-20-14-15-21-34(33)42(36-28-32(26-27-35(36)41)31-18-12-11-13-19-31)38-23-17-25-40(48-38)52-30(2)50-44(5,6)46(52,9)10;1-35(2)21-39-33(37-35)25-17-13-23(14-18-25)31-27-9-5-7-11-29(27)32(30-12-8-6-10-28(30)31)24-15-19-26(20-16-24)34-38-36(3,4)22-40-34;1-2-6-26-25(5-1)29(21-9-13-23(14-10-21)31-33-17-19-35-31)27-7-3-4-8-28(27)30(26)22-11-15-24(16-12-22)32-34-18-20-36-32/h9-36H,1-8H3;11-28H,1-10H3;5-20H,21-22H2,1-4H3;1-16H,17-20H2.

What are the key properties of 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine?

2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine has a molecular weight of 2487.23 g/mol, XLogP of 40.13, 20 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[4-[10-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,5-dihydro-1,3-oxazole;2-[4-[10-[4-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]anthracen-9-yl]phenyl]-4,4-dimethyl-5H-1,3-oxazole;2-(2,4,4,5,5-pentamethylimidazol-1-yl)-6-[10-[6-(2,4,4,5,5-pentamethylimidazol-1-yl)-2-pyridinyl]-2-phenylanthracen-9-yl]pyridine;2-[2-phenyl-10-[6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)-2-pyridinyl]anthracen-9-yl]-6-(4,4,5,5-tetramethyl-2-phenylimidazol-1-yl)pyridine is sourced from PubChem (CID 158552690), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).